William A Hein, Ii

Title: The Innovative Contributions of William A. Hein, II

Introduction

William A. Hein, II is a notable inventor based in Hasbrouck Heights, NJ (US). He has made significant contributions to the pharmaceutical industry, particularly in the development of processes for manufacturing paroxetine solid dispersions. With a total of 2 patents to his name, his work has the potential to enhance drug formulation and delivery.

Latest Patents

Hein's latest patents include an innovative aqueous process for manufacturing paroxetine solid dispersions. This process involves mixing paroxetine free base or a pharmaceutically acceptable paroxetine salt with water and a pharmaceutically acceptable polymer, followed by drying to create a composition of amorphous paroxetine and polymer. This method eliminates the need for organic solvents, which are commonly used in traditional processes. The resulting amorphous solid paroxetine composition is free from crystalline form and possesses excellent handling properties, making it suitable for use in traditional tablet dosage forms.

Another significant patent by Hein is focused on the manufacturing of solid dispersions of poorly soluble drugs. This process utilizes a solvent or fusion method, specifically employing paroxetine free base and an oil. This approach allows for lower temperatures during the fusion process, reduces the volume of organic solvents required, and facilitates the formation of a paroxetine salt during the solid dispersion manufacturing process.

Career Highlights

William A. Hein, II is currently associated with Endo Pharmaceuticals Inc., where he continues to innovate in the field of pharmaceutical formulations. His work is instrumental in addressing the challenges associated with drug solubility and bioavailability.

Collaborations

Hein has collaborated with esteemed colleagues such as Sou-Chan Chang and Philip J. Krape, contributing to the advancement of pharmaceutical technologies.

Conclusion

William A. Hein, II's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving drug formulation processes. His work not only enhances the efficacy of medications but also paves the way for future advancements in the industry.